Globe Life
GL
163.41
-2.87
-1.73%
Globe Life
US · GL
#1263 by market cap
Listed 1970
163.41
-2.87
-1.73%
Live - 5344 symbols - heartbeat 169s ago
· 2026-10-08 07:39
Pre-market
163.41
0.00%
After-hours
163.41
0.00%
- Market cap
- 12.56B
- P/E (TTM)i
- 10.87
- P/Bi
- 2.04
- EPSi
- 14.07
- Div yieldi
- 0.73%
- 52W posi
- 57%
Reader sentiment
Are you bullish or bearish on GL?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 5 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 86.32% -0.09pp
- Institutions
- 830 -5
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund73.76%
Hedge Fund4.84%
Public Company3.22%
Government Pension Fund1.41%
Private Company1.21%
Sovereign Wealth Fund1.20%
Individual/Insider0.83%
Family Office/Trust0.32%
Insurance Company0.12%
Other13.09%
Top holders as of 2026-06-30
BlackRock
7.19% · 5.53M sh
Vanguard Capital Management, LLC
7.18% · 5.52M sh
Vanguard Portfolio Management, LLC
5.44% · 4.18M sh
State Street Global Advisors
4.86% · 3.74M sh
Invesco Ltd.
3.69% · 2.84M sh
Geode Capital Management, LLC
3.65% · 2.80M sh
Dimensional Fund Advisors
3.11% · 2.39M sh
Invesco Capital Management LLC
2.32% · 1.78M sh
Eaton Vance Management
1.96% · 1.51M sh
AQR Capital Management
1.93% · 1.48M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 9 buys · 41 sells
| Name | Role | Stake |
|---|---|---|
| Frank Svoboda | Co-Chairman & Co-CEO | 0.25% |
| Robert Mitchell | Executive VP, General Counsel & Chief Risk Officer | 0.09% |
| James Darden | Co-Chairman & Co-CEO | 0.08% |
| Michael Majors | Executive VP of Policy Acquisition & Chief Strategy Officer | 0.07% |
| Thomas Kalmbach | Chief Financial Officer | 0.07% |
| Jennifer Haworth | Chief Marketing Officer | 0.03% |
| Marilyn Alexander | Independent Director | 0.03% |
| Linda Addison | Lead Independent Director | 0.03% |
| Mary Thigpen | Independent Director | 0.02% |
| Rebecca Zorn | Executive VP & Chief Talent Officer | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-21 | Robert Hensley | Executive VP & Chief Investment Officer | Derivative Exercise and Sale | -10,000 | $103.23–170.34 |
| 2026-08-13 | Frank Svoboda | Co-Chairman & Co-CEO | Intent to Sell (Form 144) | -16,500 | $177.91 |
| 2026-08-06 | Robert Mitchell | Executive VP, General Counsel & Chief Risk Officer | Derivative Exercise and Sale | -23,000 | $103.23–184.75 |
| 2026-08-04 | Robert Mitchell | Executive VP, General Counsel & Chief Risk Officer | Intent to Sell (Form 144) | -23,000 | $183.90 |
| 2026-07-30 | James Darden | Co-Chairman & Co-CEO | Derivative Exercise and Sale | -50,000 | $98.32–183.36 |
| 2026-07-29 | Thomas Kalmbach | Chief Financial Officer | Derivative Exercise and Sale | -21,000 | $103.23–181.81 |
| 2026-07-28 | Michael Majors | Executive VP of Policy Acquisition & Chief Strategy Officer | Derivative Exercise and Sale | -37,000 | $103.23–179.35 |
| 2026-07-27 | Thomas Kalmbach | Chief Financial Officer | Derivative Exercise and Sale | -25,650 | $120.49–179.42 |
| 2026-07-26 | Thomas Kalmbach | Chief Financial Officer | Intent to Sell (Form 144) | -46,650 | $173.48 |
| 2026-07-23 | Michael Majors | Executive VP of Policy Acquisition & Chief Strategy Officer | Intent to Sell (Form 144) | -37,000 | $171.08 |
| 2026-06-29 | Dolores Skarjune | Executive Vice President | Derivative Exercise and Sale | -1,850 | $103.23–179.18 |
| 2026-06-24 | Cheryl Alston | Independent Director | Derivative Exercise and Sale | -8,258 | $105.56–180.57 |
| 2026-06-24 | Cheryl Alston | Independent Director | Derivative Exercise and Retained | +5,759 | $105.56 |
| 2026-06-17 | Rebecca Zorn | Executive VP & Chief Talent Officer | Derivative Exercise and Sale | -2,000 | $98.32–170.10 |
| 2026-06-14 | Cheryl Alston | Independent Director | Intent to Sell (Form 144) | -14,017 | $166.76 |
| 2026-06-11 | Frank Svoboda | Co-Chairman & Co-CEO | Derivative Exercise and Sale | -20,000 | $100.74–166.93 |
| 2026-06-11 | Robert Mitchell | Executive VP, General Counsel & Chief Risk Officer | Other Disposition | -1,250 | -- |
| 2026-06-11 | Dolores Skarjune | Executive Vice President | Derivative Exercise and Sale | -4,175 | $98.32–167.25 |
| 2026-06-10 | Frank Svoboda | Co-Chairman & Co-CEO | Intent to Sell (Form 144) | -25,000 | $159.18 |
| 2026-05-28 | Robert Mitchell | Executive VP, General Counsel & Chief Risk Officer | Open Market Disposition | -600 | $155.55–155.57 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:39:11 · For reference only, not investment advice and not tailored to your situation.